3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
13
Breast Neoplasms
11
Carcinoma, Transitional Cell
6
Carcinoma, Non-Small-Cell Lung
5
Urinary Bladder Neoplasms
4
Neoplasm Metastasis
4
Lung Neoplasms
3
Small Cell Lung Carcinoma
2
Urothelial Bladder Carcinoma
1
Salivary Gland Neoplasms
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Prostatic Neoplasms
1
Neoplasm, Residual
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Metastatic Urothelial Cancer
1
Lung Diseases
1
Locally Advanced or Metastatic Unresectable Urothelial Cancer
1
Localized Muscle Invasive Bladder Urothelial Carcinoma
1
Liver Failure
1
HRD Cancer
1
Glioblastoma
1
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
1
Drug-Related Side Effects and Adverse Reactions
1
Carcinoma, Small Cell
1
Brain Neoplasms
1
Advanced Solid Tumors
1
Interventions
Magnetic Resonance Spectroscopy
10
Specimen Handling
9
Cisplatin
7
Radiotherapy, Intensity-Modulated
6
Platinum
6
1,2-diaminocyclohexaneplatinum II citrate
6
pembrolizumab
5
Cetuximab
5
(225)Ac-DOTA-c(RGDyK)
4
Carboplatin
3
Biopsy
3
ipatasertib
2
X-Rays
2
Taxes
2
Radiotherapy
2
Radiation
2
Paclitaxel
2
Interviews as Topic
2
Immunoglobulin G
2
Disulfides
2
peposertib
1
merphos
1
durvalumab
1
dehydroftorafur
1
cabozantinib
1
atezolizumab
1
Tretinoin
1
Surveys and Questionnaires
1
Standard of Care
1
Radiotherapy, Image-Guided
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hypopharyngeal Neoplasms
×
sacituzumab govitecan
×
90 days
×
Clear all
No trials found.